Results 61 to 70 of about 9,855 (261)

Sialidosis type I: How to alleviate disabling myoclonic seizures?—A multicenter analysis of eight cases and review of the literature

open access: yesEpilepsia Open, Volume 11, Issue 2, Page 577-591, April 2026.
Abstract Objective Sialidosis type I (ST‐1) is an autosomal‐recessive, very rare, progressive lysosomal storage disorder caused by pathogenic variants in NEU1. It is clinically characterized by progressive ataxia, myoclonic seizures (MS), bilateral tonic–clonic seizures (BTCS), and distinctive ophthalmological findings.
Janina Gburek‐Augustat   +15 more
wiley   +1 more source

The role of piracetam in treatment of sickle cell anemia

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2012
Aims & Objectives: Sickle cell anemia is a chronic hemolytic disease presented by special clinical course attributed to ischemic changes resulting from vascular occlusion by masses of sickle cells.
Hayam M. A. Mostafa   +5 more
doaj   +1 more source

Nutritional Value and Memory‐Improving Effects of Seven Major Nuts: A Comprehensive Study Using Network Pharmacology and In Vivo Assays

open access: yesFood Frontiers, Volume 7, Issue 2, March 2026.
This study highlights the memory‐enhancing effects of walnuts, almonds, and Torreya, with walnuts showing the strongest potential to improve cognitive function and delay brain aging. ABSTRACT This study explored the memory‐enhancing potential of seven commercially available nuts through nutritional profiling, metabolomics, network pharmacology, and ...
Jiamin Chen   +10 more
wiley   +1 more source

Presence of Piracetam in Cognitive Enhancement Dietary Supplements.

open access: yesJAMA Internal Medicine, 2019
Our findings demonstrate that even after the FDA re-jected an application to market piracetam as a new supplement ingredient, 3 the drug was nevertheless introduced into the marketplace.
Pieter A. Cohen   +2 more
semanticscholar   +1 more source

Oral Piracetam vs Betahistine in Outpatient Management of Peripheral Vertigo; a Randomized Clinical Trial

open access: yesArchives of Academic Emergency Medicine, 2019
Introduction: Although vertigo is a common complaint in patients presenting to the emergency department (ED), its ideal treatment is still under debate. This study was conducted to compare oral betahistine and oral piracetam in management of outpatients ...
Ali Arhami Dolatabadi   +2 more
doaj   +1 more source

Spinocerebellar Ataxia Type 2 [PDF]

open access: yes, 2012
1. Introduction: The autosomal dominant cerebellar ataxias (ADCA) are a clinically, pathologically and genetically heterogeneous group of neurodegenerative disorders caused by degeneration of cerebellum and its afferent and efferent connections.
Auburger, Georg   +3 more
core   +1 more source

Treatment approaches in posthypoxic myoclonus: A narrative review with expert opinion

open access: yesEpilepsia, Volume 67, Issue 3, Page 1049-1065, March 2026.
Abstract Acute posthypoxic myoclonus (PHM) is a neurological complication that typically emerges within 12–48 h following cardiac arrest, often in comatose patients. It can present as generalized, multifocal, or focal myoclonus and has traditionally been associated with poor prognosis.
Marina Romozzi   +7 more
wiley   +1 more source

Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function

open access: yesNeural Plasticity, 2016
The mitochondrial cascade hypothesis of dementia assumes mitochondrial dysfunction leading to reduced energy supply, impaired neuroplasticity, and finally cell death as one major pathomechanism underlying the continuum from brain aging over mild ...
Carola Stockburger   +4 more
doaj   +1 more source

POSSIBILITIES TO USE A FIXED COMBINATION OF PIRACETAM AND CINNARIZINE IN NEUROLOGICAL PRACTICE

open access: yesМедицинский совет, 2017
The article discusses  the  possibility of using the  complex drug Phezam, containing 400  mg of Piracetam and 25  mg of Cinnarizine in neurological practice.
N. V. Titova
doaj   +1 more source

Neuro-Protection and Neuro-Therapy Effects of Acalypha Indica Linn. Water Extract Ex Vivo on Musculus Gastrocnemius Frog [PDF]

open access: yes, 2008
The studies of neuro-protection and neuro-therapy effects of Acalypha indica Linn. water extract ex vivo on Musculus gastrocnemius frog have already done at three Departments in Faculty of Medicine, University of Indonesia.
Ibrahim, N. (Nurhadi)   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy